11/12/24 17:41 | 11/8/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | D | | S | -1,001 | 87.16 | 0 | -11 | -2 | 611 | D | | | | | | | | | | | | | | |
8/6/24 16:30 | 8/2/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | D | | S | -1,001 | 95.50 | 0 | -10 | -2 | 623 | D | | | | | | | | | | | | | | |
3/5/24 20:28 | 3/4/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | D | | S | -6,130 | 65.31 | 0 | -94 | -13 | 631 | D | | | | | | | | | | | | | | |
11/15/23 16:32 | 11/13/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | CEO | S | -751 | 63.72 | 0 | -12 | -2 | 697 | D | | | | | | | | | | | | | | |
8/15/23 17:35 | 8/11/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | CEO | S | -751 | 68.58 | 0 | -11 | -2 | 708 | D | | | | | | | | | | | | | | |
3/29/23 21:11 | 3/27/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | CEO | S.ad | -3,593 | 80.77 | 0 | -44 | -6 | 719 | D | | | | | | | | | | | | | | |
3/29/23 17:51 | 3/27/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | CEO | S.d | -3,593 | 80.77 | 0 | -44 | -6 | 719 | I | | | | | | | | | | | | | | |
3/10/23 17:08 | 3/8/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -752 | 74.70 | 0 | -10 | -1 | 719 | D | | | | | | | | | | | | | | |
3/6/23 21:09 | 3/3/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S.dm | -6,882 | 73.03 | 0 | -94 | -11 | 729 | D | | | | | | | | | | | | | | |
11/10/22 16:30 | 11/8/22 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -752 | 57.21 | 0 | -13 | -2 | 673 | D | | | | | | | | | | | | | | |
8/10/22 16:30 | 8/8/22 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -752 | 79.69 | 0 | -9 | -1 | 686 | D | | | | | | | | | | | | | | |
5/11/22 16:30 | 5/9/22 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -751 | 61.19 | 0 | -12 | -2 | 695 | D | | | | | | | | | | | | | | |
3/7/22 20:38 | 3/3/22 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S.dm | -1,205 | 51.63 | 0 | -23 | -3 | 707 | D | | | | | | | | | | | | | | |
3/2/22 21:06 | 2/28/22 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -2,042 | 46.50 | 0 | -44 | -6 | 656 | D | | | | | | | | | | | | | | |
1/5/22 16:43 | 1/3/22 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -403 | 28.61 | 0 | -14 | -2 | 661 | D | | | | | | | | | | | | | | |
11/15/21 16:05 | 11/10/21 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -402 | 30.12 | 0 | -13 | -2 | 675 | D | | | | | | | | | | | | | | |
8/12/21 16:30 | 8/10/21 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -402 | 25.83 | 0 | -16 | -2 | 688 | D | | | | | | | | | | | | | | |
4/14/21 16:30 | 4/12/21 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -401 | 20.66 | 0 | -19 | -3 | 704 | D | | | | | | | | | | | | | | |
3/9/21 21:06 | 3/5/21 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -496 | 18.26 | 0 | -27 | -4 | 723 | D | | | | | | | | | | | | | | |
7/27/20 16:30 | 7/23/20 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -48 | 16.02 | 0 | -3 | 0 | 605 | D | | | | | | | | | | | | | | |
7/17/20 16:30 | 7/15/20 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -354 | 16.01 | 0 | -22 | -4 | 608 | D | | | | | | | | | | | | | | |
4/29/20 16:30 | 4/27/20 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -413 | 13.77 | 0 | -30 | -5 | 634 | D | | | | | | | | | | | | | | |
3/5/20 16:31 | 3/5/20 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -138 | 15.35 | 0 | -9 | -1 | 664 | D | | | | | | | | | | | | | | |
2/28/20 16:32 | 2/26/20 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S.m | -514 | 16.27 | 0 | -32 | -6 | 524 | D | | | | | | | | | | | | | | |
2/26/20 16:30 | 2/24/20 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -159 | 16.06 | 0 | -10 | -2 | 556 | D | | | | | | | | | | | | | | |
12/23/19 16:30 | 12/20/19 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -402 | 20.85 | 0 | -19 | -3 | 563 | D | | | | | | | | | | | | | | |
9/24/19 16:30 | 9/20/19 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -402 | 25.81 | 0 | -16 | -3 | 582 | D | | | | | | | | | | | | | | |
9/5/19 16:30 | 9/3/19 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -542 | 21.21 | 0 | -26 | -4 | 598 | D | | | | | | | | | | | | | | |
6/24/19 16:30 | 6/20/19 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -400 | 27.89 | 0 | -14 | -2 | 623 | D | | | | | | | | | | | | | | |
5/22/19 16:30 | 5/20/19 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -402 | 23.89 | 0 | -17 | -3 | 638 | D | | | | | | | | | | | | | | |
4/30/19 16:30 | 4/26/19 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -741 | 24.86 | 0 | -30 | -4 | 655 | D | | | | | | | | | | | | | | |
4/16/19 16:30 | 4/12/19 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -401 | 25.40 | 0 | -16 | -2 | 684 | D | | | | | | | | | | | | | | |
3/6/19 16:30 | 3/4/19 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S.m | -217 | 23.35 | 0 | -9 | -1 | 700 | D | | | | | | | | | | | | | | |
2/27/19 16:16 | 2/25/19 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -228 | 24.06 | 0 | -9 | -1 | 709 | D | | | | | | | | | | | | | | |
2/1/19 16:30 | 1/30/19 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -157 | 16.47 | 0 | -10 | -1 | 631 | D | | | | | | | | | | | | | | |
7/14/17 16:15 | 7/12/17 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -181 | 18.05 | 0 | -10 | -2 | 592 | D | | | | | | | | | | | | | | |
6/12/17 16:05 | 6/12/17 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | DO | P,CEO | S | -154 | 15.39 | 0 | -10 | -2 | 602 | D | | | | | | | | | | | | | | |